ID   UKF-NB-6rDOX20
AC   CVCL_M476
SY   UKF-NB-6 DOX
DR   Wikidata; Q54990378
RX   PubMed=17505515;
RX   PubMed=27735941;
WW   https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
RX   PubMed=17505515; DOI=10.1038/sj.bjc.6603777;
RA   Blaheta R.A., Michaelis M., Natsheh I., Hasenberg C., Weich E.,
RA   Relja B., Jonas D., Doerr H.-W., Cinatl J. Jr.;
RT   "Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant
RT   neuroblastoma tumour cells to endothelium.";
RL   Br. J. Cancer 96:1699-1706(2007).
//
RX   PubMed=27735941; DOI=10.1038/cddis.2016.257;
RA   Voges Y., Michaelis M., Rothweiler F., Schaller T., Schneider C.,
RA   Politt K., Mernberger M., Nist A., Stiewe T., Wass M.N., Rodel F.,
RA   Cinatl J. Jr.;
RT   "Effects of YM155 on survivin levels and viability in neuroblastoma
RT   cells with acquired drug resistance.";
RL   Cell Death Dis. 7:e2410.1-e2410.11(2016).
//